• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SFXSYM PDS+ UNI VIO 18IN 1 SA CTB-1; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SFXSYM PDS+ UNI VIO 18IN 1 SA CTB-1; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE Back to Search Results
Catalog Number SXPP1A301
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.H6 component code: g07002 device not returned.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: the surgical procedure was an ovarian cancer resection, and the product was used to simultaneously suture the fascia and peritoneum.An ileus occurred after surgery, and an ileus operation was performed as a re-operation.There were no problems with the patient's subsequent process after surgery.The tab placement method and suturing completion method were performed properly.The doctors thinks that the anchor of this product may have caught in the intestine, caused an ileus.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Please provide the patient's demographic information including age, gender, weight, bmi at the time of index procedure.Date of index surgical procedure? what was the initial approach for the index surgical procedure? (open, laparoscopic or other)? what was the tissue condition (normal, thin, calcified, fragile, diseased)? when beginning the running suture, did the surgeon take the first pass above or adjacent to the incision in a direction away from the incision? after taking the first pass away from the incision, did the surgeon then take a pass of tissue perpendicular to the initial pass? if so, how many perpendicular passes? did the surgeon then proceed with wound closure in the opposite direction of the first pass? was the fixation tab seated against the tissue at the initiation of suture use during the index procedure? were two reverse stitches performed across the incision prior to closure? what symptoms did the patient experience following the index surgical procedure? onset date? how many days post-op did the ileus occur? please describe any medical/surgical intervention required for this suture event including dates and results.Did the operating surgeon observe any suture deficiency or anomaly before, during, after the suture placement or during any re-operation? can you describe the appearance of the stratafix suture during second procedure other relevant patient history/concomitant medications? what is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status? lot number?.
 
Event or Problem Description
It was reported that a patient underwent an ovarian cancer resection on an unknown date and a barbed suture was used to simultaneously suture the fascia and peritoneum.It was stated that the tab placement method and suturing completion method were performed properly.Post-op, the patient experienced an intestinal obstruction and an ileus.A re-operation was performed.There were no problems with the patient's subsequent process after surgery.The physicians opined that the anchor of the device may have been caught in the intestine, causing an ileus.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested, and the following was obtained: please provide the patient's demographic information including age, gender, weight, bmi at the time of index procedure unk.Date of index surgical procedure? unk.What was the initial approach for the index surgical procedure? (open, laparoscopic or other)? open surgery (ovarian cancer resection).What was the tissue condition (normal, thin, calcified, fragile, diseased)? unk.When beginning the running suture, did the surgeon take the first pass above or adjacent to the incision in a direction away from the incision? unk.After taking the first pass away from the incision, did the surgeon then take a pass of tissue perpendicular to the initial pass? if so, how many perpendicular passes? unk.Did the surgeon then proceed with wound closure in the opposite direction of the first pass? unk.Was the fixation tab seated against the tissue at the initiation of suture use during the index procedure? yes, the fixation tab was properly seated.Were two reverse stitches performed across the incision prior to closure? unk.What symptoms did the patient experience following the index surgical procedure? onset date? postoperative ileus occurred.Onset date is unk.How many days post-op did the ileus occur? unk.Please describe any medical/surgical intervention required for this suture event including dates and results.A second surgery was performed to relieve the ileus.The patient¿s postoperative course was uneventful after the intervention.Did the operating surgeon observe any suture deficiency or anomaly before, during, after the suture placement or during any re-operation? the surgeon suspects that the anchor of the stratafix suture may have caught on the intestinal tract, potentially causing the ileus.Can you describe the appearance of the stratafix suture during second procedure unk.Other relevant patient history/concomitant medications? unk.What is the physician¿s opinion as to the etiology of or contributing factors to this event? the physician suspects that the anchor of the stratafix suture may have contributed to the ileus by catching on the bowel.What is the patient's current status? stable.Lot number? unk.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SFXSYM PDS+ UNI VIO 18IN 1 SA CTB-1
Common Device Name
SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
calle durango #2751
ciudad juarez 32575
MX   32575
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
3035526892
MDR Report Key22642758
Report Number2210968-2025-08731
Device Sequence Number20996112
Product Code NEW
UDI-Device Identifier10705031227712
UDI-Public10705031227712
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
K141776
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 09/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberSXPP1A301
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/02/2025
Supplement Date Received by Manufacturer09/11/2025
Initial Report FDA Received Date07/29/2025
Supplement Report FDA Received Date09/12/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-